ROOTED
IN EUROPE
CONNECTED WORLDWIDE
The GetReal Institute builds on more than a decade of collaboration and innovation in real-world evidence (RWE). Our roots lie in two influential programmes funded by the Innovative Medicines Initiative (IMI), which created the foundation for today’s independent, multi-stakeholder platform.
Our mission is to advance the science, methods, and application of Real-World Evidence (RWE) to support regulatory, Health Technology Assessment (HTA), and clinical decision-making across Europe and beyond.
2013
GetReal Project IMI Funded Call 7
Established to demonstrate how robust new methods of real-world data (RWD) could be adopted earlier in pharmaceutical research and healthcare decision-making.
2018
GetReal Initiative IMI Funded Call 11
Developed tools, methodologies and best practice to increase the quality of real-world evidence (RWE) generation in medicines development and regulatory/HTA processes in Europe.
2021
GetReal Institute
Established as an independent, non-profit forum bringing together regulators, HTA bodies, payers, industry, academia, and patients to advance the adoption and implementation of RWE in healthcare.
2025
Topic-Based Collaboration
The GetReal Institute has evolved to a flexible topic-based research programme, enabling members to shape the RWE agenda and rapidly establish new Topic Groups as priorities and challenges emerge.
Shape the future of Real-World Evidence
Join the GetReal Institute
Connect with leading experts, innovators, and decision-makers shaping the future of real-world evidence across Europe and beyond.
As a member of GetReal Institute, you will join a collaborative community working to advance the science, methods, and use of RWE in healthcare decision-making. Members contribute to expert-led Topic Groups, collaborative research, training programmes, and cross-sector initiatives addressing key scientific, methodological, and policy challenges.
Membership provides opportunities to shape the RWE agenda, build strategic collaborations, access practical insights and training, and contribute to impactful outputs that inform the future of healthcare decision-making.
Our Members
Membership Categories
We offer several membership options to accommodate the diverse organisations involved in the generation and use of real-world evidence (RWE). Each category reflects a specific role within the healthcare ecosystem.
Open to national and international public bodies involved in healthcare regulation, assessment, or funding. This includes regulatory agencies, health technology assessment (HTA) bodies, and publicly funded institutions. These members provide critical policy and system-level perspectives.
1 Year Annual Plan:
A membership year runs from 1 January – 31 December, and is automatically renewed.
Membership Fee: €1,200
3 Year Annual Plan:
20% discount for 3-year membership, recognising the value of sustained participation & collaboration.
Membership Fee: €2,880
We offer several membership options to accommodate the diverse organisations involved in the generation and use of real-world evidence (RWE). Each category reflects a specific role within the healthcare ecosystem.
For non-profit organisations and foundations focused on public health, patient advocacy, healthcare quality, or equitable access. NGOs provide independent, community-focused perspectives and play a key role in ensuring patient and societal interests are represented.
1 Year Annual Plan:
A membership year runs from 1 January – 31 December, and is automatically renewed.
Membership Fee: €400
3 Year Annual Plan:
20% discount for 3-year membership, recognising the value of sustained participation & collaboration.
Membership Fee: €960
We offer several membership options to accommodate the diverse organisations involved in the generation and use of real-world evidence (RWE). Each category reflects a specific role within the healthcare ecosystem.
For universities, academic institutes, and public research centres conducting research in health, data science, epidemiology, or related fields. Academic members offer methodological expertise and contribute to the development and validation of RWE approaches
1 Year Annual Plan:
A membership year runs from 1 January – 31 December, and is automatically renewed.
Membership Fee: €1,200
3 Year Annual Plan:
20% discount for 3-year membership, recognising the value of sustained participation & collaboration.
Membership Fee: €2,880
We offer several membership options to accommodate the diverse organisations involved in the generation and use of real-world evidence (RWE). Each category reflects a specific role within the healthcare ecosystem.
Includes pharmaceutical biotechnology, medical technology companies, and contract research organisations (CROs). These members bring practical insights from evidence generation, innovation, and implementation in healthcare product development.
1 Year Annual Plan:
A membership year runs from 1 January – 31 December, and is automatically renewed.
Membership Fee: €34,000 – Large Company (>1,000 employees)
Membership Fee: €17,000 – Medium Company (250-1,000 employees)
Membership Fee: €6,000 – Small Company (<250 employees)
3 Year Annual Plan:
20% discount for 3-year membership, recognising the value of sustained participation & collaboration.
Membership Fee: €81,600 – Large Company (>1,000 employees)
Membership Fee: €40,800– Medium Company (250-1,000 employees)
Membership Fee: €14,400 – Small Company (<250 employees)
Current Executive Board
Academia Seat
University Medical Center Utrecht (UMCU)
Patient Organisation seat
EURORDIS Rare Diseases Europe
HTA seat
Institute of Healthcare and Excellence (NICE)
Life Sciences Seat
Sanofi
Academia Seat
Utrecht University (UU)
Life Sciences Seat
Pfizer
Commercial Service Provider Seat
Thermo Fisher Scientific
Secretariat
Mariam Bibi
Managing Director
Roos Steevels
Administrative Coordinator
